Trailing-twelve-month (TTM) revenue is $1.04 Billion with a year-over-year growth of +1.36%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-11-01 | $246,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-03 |
| Q3 FY2026Period ended 2026-01-31 | $233,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q4 FY2026Period ended 2026-05-02 | $298,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-24 |
| Q1 FY2027Period ended 2026-08-01 | $265,399,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-02 |
| TTM revenue | $1,044,099,999 |
Current P/S: $524,627,922 market capitalization ÷ $1,044,099,999 TTM revenue = 0.50x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T15:54:54.000Z. Latest revenue period ended 2026-08-01.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-08-01): $265.40M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-25T15:55:52.941Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-05-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-05-02 · USD | FY20212021-05-01 · USD | FY20222022-04-30 · USD | FY20232023-04-29 · USD | FY20242024-04-27 · USD | FY20252025-05-03 · USD |
|---|---|---|---|---|---|---|
| Automotive | $717M | $406M | $401M | $742M | $611M | $522M |
| Corporate And Intersegment Elimination | $7M | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-05-02 · USD | FY20212021-05-01 · USD | FY20222022-04-30 · USD | FY20232023-04-29 · USD | FY20242024-04-27 · USD | FY20252025-05-03 · USD |
|---|---|---|---|---|---|---|
| Asia | N/A | N/A | N/A | $241M | N/A | N/A |
| CANADA | $20M | $15M | N/A |
$1.04B
$1.04 Billion
+1.36%
vs. $1.03B a year ago (TTM)
(2.50%)
5 Year compound annual growth rate
1 Year
+1.36%
3 Year
(4.17%)
5 Year
(2.50%)
10 Year
+2.73%
15 Year
+5.93%
20 Year
+4.51%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.02B | ($28.90M) | (2.76%) |
| 2025 | $1.05B | ($66.40M) | (5.96%) |
| 2024 | $1.11B | ($65.10M) | (5.52%) |
| 2023 | $1.18B | +$16.00M | +1.38% |
| 2022 | $1.16B | +$75.60M | +6.95% |
| 2021 |
TTM Growth
+1.36%
3-Year CAGR
(4.17%)
5-Year CAGR
(2.50%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-25T15:55:52.941Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
2025-05-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| -$24M |
| -$46M |
| $53M |
| Industrial | $254M | $143M | $177M | $403M | $493M | $527M |
|---|
| Interface | $59M | $61M | $59M | $55M | $54M | $52M |
|---|
| Medical | $2M | $3M | $4M | $4M | $2M | N/A |
|---|
| N/A |
| N/A |
| N/A |
| CHINA | N/A | $194M | $224M | N/A | $196M | $126M |
|---|
| EGYPT | N/A | N/A | $67M | N/A | $74M | $100M |
|---|
| EMEA | N/A | N/A | N/A | $371M | N/A | N/A |
|---|
| MALTA | N/A | $174M | $178M | N/A | $180M | $202M |
|---|
| MEXICO | N/A | $87M | $76M | N/A | N/A | N/A |
|---|
| Other Countries | $127M | N/A | N/A | N/A | $123M | $117M |
|---|
| Other Countries Sales | $107M | $108M | $70M | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | $511M | $547M | N/A | $476M | $445M |
|---|
| $1.09B |
| +$64.10M |
| +6.26% |
| 2020 | $1.02B | +$23.60M | +2.36% |
| 2019 | $1.00B | +$92.00M | +10.13% |
| 2018 | $908.30M | +$91.80M | +11.24% |
| 2017 | $816.50M | +$7.40M | +0.91% |
